These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 34520409)

  • 1. Moraxella Keratitis: A Case Series.
    Kenny SE; Puig M; Salinas R; Johnson DA; Kheirkhah A
    Eye Contact Lens; 2021 Dec; 47(12):674-676. PubMed ID: 34520409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methicillin-Resistant Staphylococcus aureus Keratitis: Initial Treatment, Risk Factors, Clinical Features, and Treatment Outcomes.
    Durrani AF; Atta S; Bhat AK; Mammen A; Dhaliwal D; Kowalski RP; Jhanji V
    Am J Ophthalmol; 2020 Jun; 214():119-126. PubMed ID: 32209347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Characteristics of 17 Patients with Moraxella Keratitis.
    Tobimatsu Y; Inada N; Shoji J; Yamagami S
    Semin Ophthalmol; 2018; 33(5):726-732. PubMed ID: 29308970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Characteristics and Bacteriological Profile of Moraxella Keratitis.
    Inoue H; Suzuki T; Inoue T; Hattori T; Nejima R; Todokoro D; Hoshi S; Eguchi H; Miyamoto H; Ohashi Y
    Cornea; 2015 Sep; 34(9):1105-9. PubMed ID: 25970435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bilateral Moraxella Keratitis in a Healthy Person after an Episode of Conjunctivitis: A Case Report.
    Bajracharya L; Singh Rana R
    JNMA J Nepal Med Assoc; 2021 May; 59(237):510-512. PubMed ID: 34508430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence, Clinical Profile, and Management of Keratitis Caused by Uncommon Species of Pseudomonas at a Tertiary Eye Care Center.
    Thamizhselvi S; Pooja A; Prajna L; Rameshkumar G; Prajna NV; Karpagam R
    Cornea; 2023 Mar; 42(3):359-364. PubMed ID: 36729653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and microbiological characteristics of Moraxella keratitis.
    McSwiney TJ; Knowles SJ; Murphy CC
    Br J Ophthalmol; 2019 Dec; 103(12):1704-1709. PubMed ID: 30709811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Moraxella Keratitis: Analysis of Risk Factors, Clinical Characteristics, Management, and Treatment Outcomes.
    Durrani AF; Faith SC; Kowalski RP; Yu M; Romanowski E; Shanks R; Dhaliwal D; Jhanji V
    Am J Ophthalmol; 2019 Jan; 197():17-22. PubMed ID: 30201340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infectious keratitis after Boston type 1 keratoprosthesis implantation.
    Chan CC; Holland EJ
    Cornea; 2012 Oct; 31(10):1128-34. PubMed ID: 22960647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microbial Keratitis and Ocular Surface Disease: A 5-Year Study of the Microbiology, Risk Factors and Clinical Outcomes in Sydney, Australia.
    Khoo P; Cabrera-Aguas M; Robaei D; Lahra MM; Watson S
    Curr Eye Res; 2019 Nov; 44(11):1195-1202. PubMed ID: 31189397
    [No Abstract]   [Full Text] [Related]  

  • 11. Moraxella keratitis: epidemiology and outcomes.
    Hoarau G; Merabet L; Brignole-Baudouin F; Mizrahi A; Borderie V; Bouheraoua N
    Eur J Clin Microbiol Infect Dis; 2020 Dec; 39(12):2317-2325. PubMed ID: 32648113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment outcome of Moraxella keratitis: our experience with 18 cases--a retrospective review.
    Garg P; Mathur U; Athmanathan S; Rao GN
    Cornea; 1999 Mar; 18(2):176-81. PubMed ID: 10090363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Characteristics and Outcomes of Moraxella Keratitis.
    Zafar H; Tan SZ; Walkden A; Fullwood C; Au L; Brahma A; Carley F
    Cornea; 2018 Dec; 37(12):1551-1554. PubMed ID: 30222715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors, clinical features and outcomes of Neisseria keratitis.
    Kate A; Bagga B; Ramazanova K; Joshi V; Mohamed A; Sharma S
    Int Ophthalmol; 2021 Oct; 41(10):3361-3369. PubMed ID: 34047910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Moraxella species: infectious microbes identified by use of time-of-flight mass spectrometry.
    Takahashi S; Murata K; Ozawa K; Yamada H; Kawakami H; Nakayama A; Asano Y; Mochizuki K; Mikamo H
    Jpn J Ophthalmol; 2019 Jul; 63(4):328-336. PubMed ID: 31273564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bacillus cereus keratitis associated with contact lens wear.
    Pinna A; Sechi LA; Zanetti S; Usai D; Delogu G; Cappuccinelli P; Carta F
    Ophthalmology; 2001 Oct; 108(10):1830-4. PubMed ID: 11581057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infectious keratitis progressing to endophthalmitis: a 15-year study of microbiology, associated factors, and clinical outcomes.
    Henry CR; Flynn HW; Miller D; Forster RK; Alfonso EC
    Ophthalmology; 2012 Dec; 119(12):2443-9. PubMed ID: 22858123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paediatric infectious keratitis: a case series of 107 children presenting to a tertiary referral centre.
    Rossetto JD; Cavuoto KM; Osigian CJ; Chang TCP; Miller D; Capo H; Spierer O
    Br J Ophthalmol; 2017 Nov; 101(11):1488-1492. PubMed ID: 28298316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolving risk factors and antibiotic sensitivity patterns for microbial keratitis at a large county hospital.
    Jin H; Parker WT; Law NW; Clarke CL; Gisseman JD; Pflugfelder SC; Wang L; Al-Mohtaseb ZN
    Br J Ophthalmol; 2017 Nov; 101(11):1483-1487. PubMed ID: 28336675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of ofloxacin vs cefazolin and tobramycin in the therapy for bacterial keratitis. Report from the Bacterial Keratitis Study Research Group.
    O'Brien TP; Maguire MG; Fink NE; Alfonso E; McDonnell P
    Arch Ophthalmol; 1995 Oct; 113(10):1257-65. PubMed ID: 7575256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.